Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404843 · ClinicalTrials.gov registry record · Phase 2
Red Blood Cell ATP Release and Vascular Function in Humans
A Phase 2 study, sponsored by Colorado State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
NCT03404843 is a Phase 2 study that has completed, run by Colorado State University. The registered enrollment target is 31 participants.
The verdict
NCT03404843, a Phase 2 study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
Study Summary
Previous work demonstrates that the red blood cells of older adults do not release a potent vasodilator (ATP) as well as the red blood cells of younger adults. The investigators are targeting a pathway within the red blood cell using fasudil hydrochloride to determine if both the release of ATP from red blood cells and blood flow responses to low oxygen (hypoxia) and exercise in older adults can be improved.
Interventions
- OTHER Saline
- DRUG Fasudil Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-07-14 |
| Est. Completion | 2018-10-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404843
The ClinicalTrials.gov registry entry for NCT03404843 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT03404843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03404843 about?
NCT03404843 is a clinical study titled "Red Blood Cell ATP Release and Vascular Function in Humans". Previous work demonstrates that the red blood cells of older adults do not release a potent vasodilator (ATP) as well as the red blood cells of younger adults. The investigators are targeting a pathway within the red blood cell using fasudil hydrochloride to determine if both the release of ATP from...
What is the current status of trial NCT03404843?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2017-07-14. Estimated completion is 2018-10-05.
What interventions are being tested in trial NCT03404843?
The interventions under investigation include: Saline (OTHER), Fasudil Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03404843?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.